Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Sustained Unresponsiveness (SU) to Sesame Protein Following Low-dose Oral Allergen-specific Immunotherapy [NA]

View source ↗

Summary

This clinical trial examines whether low-dose oral immunotherapy with sesame protein can induce sustained unresponsiveness in children with sesame-related food …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sesame protein oral immunotherapy (sesame protein oral immunotherapy)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Food Allergy in Children | NA | Status: NOT_YET_RECRUITING